跳到主要內容區塊
  1. 首頁
  2. 論文發表

論文發表

論文發表列表

2025

    1. Chang TC, Wang CM, Ho CH, Chen YC, Liao CT, Shieh JM, Chang WT. A prevalence study focusing on hospitalized COPD related pulmonary hypertension. Sci Rep. 2025 Apr 11;15(1):12426. doi: 10.1038/s41598-025-96629-9. PMID: 40216921; PMCID: PMC11992209. https://doi.org/10.1038/s41598-025-96629-9
    2. Chang WT, Lin HW, Liu CH, Lin SH, Li YH. Association between immune checkpoint inhibitors and cardiovascular risks: a nationwide self-controlled case series study. Am J Cancer Res. 2025 Apr 15;15(4):1820-1828. doi: 10.62347/ZUUA2691. PMID: 40371149; PMCID: PMC12070085.https://doi.org/10.62347/zuua2691
    3. Chang WT, Wu CC, Liao IC, Lin YW, Chen YC, Ho CH, Lee WC, Lin YC, Chen ZC, Shih JY, Wu NC, Kan WC. Corrigendum to "Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-a translational study" [Free Radic. Biol. Medi. 208 (2023) 103-111]. Free Radic Biol Med. 2025 Jun;233:422-423. doi: 10.1016/j.freeradbiomed.2025.04.002. Epub 2025 Apr 7. Erratum for: Free Radic Biol Med. 2023 Nov 1;208:103-111. doi: 10.1016/j.freeradbiomed.2023.08.013. PMID: 40199665. https://doi.org/10.1016/j.freeradbiomed.2025.04.002
    4. Chen CL, Yang WS, Yang HI, Chen CF, Wang LY, Lu SN, Kao JH, Chen PJ, Chen CJ. Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study. Liver Cancer. 2024 Jun 21;14(1):19-35. doi: 10.1159/000539909. PMID: 40144469; PMCID: PMC11936446. https://doi.org/10.1159/000539909
    5. Chen WY, Shih HL, Lee YT, Chang R, Liang WM, Hung YM, Sun CK. Risk of acute myocardial infarction in patients with non-typhoidal Salmonella infection: A nationwide matched population-based cohort study. Public Health. 2025 May;242:406-412. doi: 10.1016/j.puhe.2025.03.019. Epub 2025 Apr 10. PMID: 40215913. https://doi.org/10.1016/j.puhe.2025.03.019
    6. Chen YC, Tsai PC, Huang CF, Chen CY, Hung CH, Chen CH, Tai CM, Cheng PN, Kuo HT, Mo LR, Lo CC, Huang YH, Lin HC, Lee PL, Bair MJ, Chang TS, Lin CY, Wang SJ, Hsieh TY, Yang TH, Peng CY, Yang CC, Chong LW, Huang CW, Lin CW, Chu CH, Tsai MC, Kao JH, Liu CJ, Chuang WL, Tseng KC, Yu ML; TACR investigators. High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C. J Formos Med Assoc. 2025 Feb 6:S0929-6646(25)00042-7. doi: 10.1016/j.jfma.2025.01.026. Epub ahead of print. PMID: 39919992. https://doi.org/10.1016/j.jfma.2025.01.026
    7. Chen YY, Chen CS, Huang JF, Su WH, Li CY, Chen WS, Lin ES, Chuang WL, Yu ML, Wang SC. The obesity-related mutation gene on nonalcoholic fatty liver disease. Hum Genet. 2025 Jan;144(1):1-14. doi: 10.1007/s00439-024-02686-x. Epub 2024 Jul 10. PMID: 38985322. https://doi.org/10.1007/s00439-024-02686-x
    8. Eslam M, Fan JG, Yu ML, Wong VW, Cua IH, Liu CJ, Tanwandee T, Gani R, Seto WK, Alam S, Young DY, Hamid S, Zheng MH, Kawaguchi T, Chan WK, Payawal D, Tan SS, Goh GB, Strasser SI, Viet HD, Kao JH, Kim W, Kim SU, Keating SE, Yilmaz Y, Kamani L, Wang CC, Fouad Y, Abbas Z, Treeprasertsuk S, Thanapirom K, Al Mahtab M, Lkhagvaa U, Baatarkhuu O, Choudhury AK, Stedman CAM, Chowdhury A, Dokmeci AK, Wang FS, Lin HC, Huang JF, Howell J, Jia J, Alboraie M, Roberts SK, Yoneda M, Ghazinian H, Mirijanyan A, Nan Y, Lesmana CRA, Adams LA, Shiha G, Kumar M, Örmeci N, Wei L, Lau G, Omata M, Sarin SK, George J. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27. PMID: 40016576. https://doi.org/10.1007/s12072-024-10774-3
    9. Hong CS, Wu NC, Lin YW, Lin YC, Shih JY, Niu KC, Lin MT, Chang CP, Chen ZC, Kan WC, Chang WT. Hyperbaric oxygen therapy attenuated limb ischemia in mice with high-fat diet by restoring Sirtuin 1 and mitochondrial function. Free Radic Biol Med. 2025 Mar 16;230:263-272. doi: 10.1016/j.freeradbiomed.2025.01.056. Epub 2025 Feb 14. PMID: 39956474. https://doi.org/10.1016/j.freeradbiomed.2025.01.056
    10. Hsu CH, Chen CF, Yin CH, Chen YS, Chen JS. Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan. Oncology. 2025 Mar 28:1-10. doi: 10.1159/000545458. Epub ahead of print. PMID: 40159404. https://doi.org/10.1159/000545458
    11. Hua CH, Lin JC, Wen YW, Kang CJ, Lin CY, Ku HY, Fan KH, Ng SH, Lee SR, Tsai YT, Chen WC, Lee LY, Chien CY, Wang CP, Che TM, Terng SD, Tsai CY, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma? Oral Oncol. 2025 Mar;162:107198. doi: 10.1016/j.oraloncology.2025.107198. Epub 2025 Jan 28. PMID: 39879895. https://doi.org/10.1016/j.oraloncology.2025.107198
    12. Huang CF, Yeh ML, Dai CY, Huang JF, Chuang WL, Yu ML. Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on "Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan". Clin Mol Hepatol. 2025 Jan;31(1):e64-e66. doi: 10.3350/cmh.2024.0638. Epub 2024 Aug 19. PMID: 39159946; PMCID: PMC11791571. https://doi.org/10.3350/cmh.2024.0638
    13. Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH. Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues. Clin Mol Hepatol. 2025 Jul;31(3):1003-1017. doi: 10.3350/cmh.2024.1070. Epub 2025 Mar 17. PMID: 40091278; PMCID: PMC12260618. https://doi.org/10.3350/cmh.2024.1070
    14. Jang TY, Zeng YT, Liang PC, Wu CD, Wei YJ, Tsai PC, Hsieh MY, Lin YH, Hsieh MH, Wang CW, Yang JF, Yeh ML, Huang CF, Chuang WL, Huang JF, Cheng YY, Dai CY, Chen PC, Yu ML. Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Aliment Pharmacol Ther. 2025 May;61(9):1458-1466. doi: 10.1111/apt.70019. Epub 2025 Feb 19. PMID: 39968810. https://doi.org/10.1111/apt.70019
    15. Jang TY, Zeng YT, Liang PC, Wu CD, Wei YJ, Tsai PC, Hsu PY, Hsieh MY, Lin YH, Hsieh MH, Wang CW, Yang JF, Yeh ML, Huang CF, Chuang WL, Huang JF, Cheng YY, Dai CY, Chen PC, Yu ML. Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Liver Int. 2025 Apr;45(4):e16149. doi: 10.1111/liv.16149. Epub 2024 Nov 26. PMID: 39588868. https://doi.org/10.1111/liv.16149
    16. Kang CJ, Wen YW, Lin CY, Ng SH, Tsai YT, Ku HY, Lou PJ, Wang CP, Lin JC, Hua CH, Lee SR, Fan KH, Chen WC, Lee LY, Chien CY, Chen TM, Terng SD, Tsai CY, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide study. Oral Oncol. 2025 Feb;161:107196. doi: 10.1016/j.oraloncology.2025.107196. Epub 2025 Jan 21. PMID: 39842233. https://doi.org/10.1016/j.oraloncology.2025.107196
    17. Kuo YH, Ong KH, Sun DP, Tian YF, Chou CL, Chan TC, Hsing CH, Li WS, Li CF, Shiue YL. Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma. Virchows Arch. 2025 Jun;486(6):1199-1210. doi: 10.1007/s00428-025-04081-x. Epub 2025 Mar 28. PMID: 40153004; PMCID: PMC12213841. https://doi.org/10.1007/s00428-025-04081-x
    18. Lee WC, Lin YW, Shih JY, Chen ZC, Wu NC, Chang WT, Liu PY. Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model. Biomol Biomed. 2025 Jan 30;25(3):608-622. doi: 10.17305/bb.2024.11361. PMID: 39636756; PMCID: PMC12010975. https://doi.org/10.17305/bb.2024.11361
    19. Lin HY, Chen IY, Wang TM, Yen CH, Chen Y, Chen YH, Dai DF, Huang JF, Chiu YW, Yang MY. The Role of Mitochondrial AKT1 Signaling in Renal Tubular Injury of Metabolic Syndrome. Kidney Int Rep. 2024 Dec 24;10(3):906-920. doi: 10.1016/j.ekir.2024.12.021. Erratum in: Kidney Int Rep. 2025 Aug 20;10(10):3714. doi: 10.1016/j.ekir.2025.08.001. PMID: 40225378; PMCID: PMC11993225. https://doi.org/10.1016/j.ekir.2024.12.021
    20. Lu MY, Wei YJ, Wang CW, Liang PC, Yeh ML, Tsai YS, Tsai PC, Ko YM, Lin CC, Chen KY, Lin YH, Jang TY, Hsieh MY, Lin ZY, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes. World J Gastroenterol. 2025 Mar 14;31(10):103716. doi: 10.3748/wjg.v31.i10.103716. PMID: 40093674; PMCID: PMC11886537. https://doi.org/10.3748/wjg.v31.i10.103716
    21. Tsai MH, Yang CH, Tsai YT, Lin YT, Chao CY, Chuang HC, Huang TL, Lu H, Tsai WL, Chien CY*, Fang FM. Controlling nutritional status score as a survival prognosticator in patients with head and neck cancer. J Formos Med Assoc. 2025 Apr 16:S0929-6646(25)00186-X. doi: 10.1016/j.jfma.2025.04.017. Epub ahead of print. PMID: 40246675. https://doi.org/10.1016/j.jfma.2025.04.017
    22. Tsai YT, Wen YW, Tsai TY, Lin CY, Ng SH, Ku HY, Lou PJ, Wang CP, Lin JC, Hua CH, Lee SR, Fan KH, Chen WC, Lee LY, Chien CY, Chen TM, Terng SD, Tsai CY, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Kang CJ, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort study. Oral Oncol. 2025 May;164:107289. doi: 10.1016/j.oraloncology.2025.107289. Epub 2025 Apr 3. PMID: 40184884. https://doi.org/10.1016/j.oraloncology.2025.107289
    23. Tseng TC, Hosaka T, Pan MH, Liu CJ, Suzuki F, Chen CJ, Su TH, Kumada H, Yang WT, Yang HC, Liu CH, Chen PJ, Yang HI, Kao JH. Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients. Hepatology. 2026 Jan 1;83(1):142-155. doi: 10.1097/HEP.0000000000001313. Epub 2025 Mar 20. PMID: 40112297. https://doi.org/10.1097/hep.0000000000001313
    24. Wang SJ, Huang CF, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Kuo HT, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Wang SC, Yu ML. Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan. Kaohsiung J Med Sci. 2025 Feb;41(2):e12929. doi: 10.1002/kjm2.12929. Epub 2025 Jan 19. PMID: 39829106; PMCID: PMC11827544. https://doi.org/10.1002/kjm2.12929
    25. Wong LS, Yang JL, Yen YT, Lee CH, Yang JH. Endothelin-1 Participates in the Pathogenesis of Prurigo Nodularis by Promoting NGF Expression via Endothelial Receptor B in Epidermal Keratinocytes and Dorsal Root Ganglion Cells. Allergy. 2025 May;80(5):1530-1533. doi: 10.1111/all.16564. Epub 2025 Apr 18. PMID: 40249388; PMCID: PMC12105065. https://doi.org/10.1111/all.16564
    26. Yang CY, Chen JH, Chen CY, Kao CY, Huang SF, Chang WY, Tu HP, Huang JF, Yu ML, Tai CM. Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort study. Surg Obes Relat Dis. 2025 May;21(5):537-546. doi: 10.1016/j.soard.2024.11.007. Epub 2024 Nov 29. PMID: 39706718. https://doi.org/10.1016/j.soard.2024.11.007
    27. Yen LJ, Yen CY, Li CL, Liao EC, Wang KC, Shih MC, Huang HS, Chen YC, Lu LY, Yu SJ. RETRACTED: Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J Pers Med. 2022 Nov 10;12(11):1888. doi: 10.3390/jpm12111888. Retraction in: J Pers Med. 2025 Feb 18;15(2):72. doi: 10.3390/jpm15020072. PMID: 36579613; PMCID: PMC9693458. https://doi.org/10.3390/jpm15020072
    28. Zhang T, Huang CJ, Chen HT, Huang YH, Pan MH, Lee MH, Viard M, Hildesheim A, Pfeiffer RM, Carrington M, Chen CJ, Zhu B, Lenz TL, Jiang D, Yang HI, Liu Z. HLA-DQB1*03:01 and risk of HBV-related HCC. Hepatology. 2026 Feb 1;83(2):374-386. doi: 10.1097/HEP.0000000000001307. Epub 2025 Mar 14. PMID: 40084945; PMCID: PMC12353533. https://doi.org/10.1097/hep.0000000000001307
    29. Chuang HC, Tsai MH, Chuang JH, Hong YT, Chien CY*, Chou MH. ONC201 enhances the cytotoxic effect of cisplatin through ATF3/ATF4/CHOP in head and neck squamous cell carcinoma cells. Oncogenesis. 2025 Jun 18;14(1):20. doi: 10.1038/s41389-025-00563-4. PMID: 40533448; PMCID: PMC12177087. https://pubmed.ncbi.nlm.nih.gov/40533448/
    30. Tsai MH, Yang CH, Tsai YT, Lin YT, Chao CY, Chuang HC, Huang TL, Lu H, Tsai WL, Chien CY, Fang FM. Controlling nutritional status score as a survival prognosticator in patients with head and neck cancer. J Formos Med Assoc. 2025 Apr 16:S0929-6646(25)00186-X. doi: 10.1016/j.jfma.2025.04.017. Epub ahead of print. PMID: 40246675. https://pubmed.ncbi.nlm.nih.gov/40246675/
    31. Tsai MH, Yang CH, Lin YT, Chuang HC, Huang TL, Lu H, Tsai WL, Chien CY*, Fang FM*. Albumin-Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma. Kaohsiung J Med Sci. 2025 Sep 25:e70115. doi: 10.1002/kjm2.70115. Epub ahead of print. PMID: 40999594. https://doi.org/10.1002/kjm2.70115
    32. Wu PY, Tsai YT, Lin YT, Chuang HC, Yang CH, Chien CY, Fang FM, Huang TL, Lu H, Tsai MH. Assessment of Preoperative Systemic Inflammation Response Index in Surgically Treated Young Head and Neck Cancer Patients Under 40. Ear Nose Throat J. 2025 May 6:1455613251338940. doi: 10.1177/01455613251338940. Epub ahead of print. PMID: 40327049. https://doi.org/10.1177/01455613251338940
    33. Huang YJ, Chou SY, Tsai MH, Chuang HC, Chien CY, Tsai WL, Fang FM, Su YY. Prospective longitudinal study of patient-reported dysphagia in nasopharyngeal carcinoma treated with intensity-modulated proton therapy. J Formos Med Assoc. 2025 Jun 26:S0929-6646(25)00326-2. doi: 10.1016/j.jfma.2025.06.035. Epub ahead of print. PMID: 40579270. https://doi.org/10.1016/j.jfma.2025.06.035
    34. Su YY, Chien CY, Tsai WL, Tsai MH, Fang FM. Preoperative Systemic Inflammation Response Index Predicts Survival Outcome for Previously Irradiated Metachronous Secondary Head and Neck Cancer Patients. Cancer Manag Res. 2025 Sep 29;17:2221-2233. doi: 10.2147/CMAR.S542599. PMID: 41050885; PMCID: PMC12493848. https://doi.org/10.2147/CMAR.S542599
    35. Hsiao PW, Lin YT, Chuang HC, Chao CY, Chien CY, Yang CH, Fang FM, Lu H, Tsai MH. Impact of Depth of Invasion in Node-Negative Oral Tongue Cancer Treated With Surgery Alone. Kaohsiung J Med Sci. 2025 Sep 1:e70102. doi: 10.1002/kjm2.70102. Epub ahead of print. PMID: 40888657. https://doi.org/10.1002/kjm2.70102
    36. Chen HH, Chen CH, Hou MC, Fu YC, Li LH, Chou CY, Yeh EC, Tsai MF, Chen CH, Yang HC, Huang YT, Liu YM, Wei CY, Su JP, Lin WJ, Wang EHF, Chiang CL, Jiang JK, Lee IH, Liang KH, Chen WS, Tsai HC, Lin SY, Chang FP, Ho HL, Yeh YC, Tseng WC, Lin MH, Chang HT, Tseng LM, Liang WY, Chen PC, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Chen MY, Lin YC, Kao YT, Kao BZ, Lee JE, Chung CL, Liu JC, Chan P, Lin CH, Chen CH, Wu IC, Lin LC, Wang JW, Shih SL, Hsieh SW, Hung CH, Li WM, Yang CJ, Yang CS, Weng RH, Chen YC, Chang CP, Wu TH, Lin YC, Sheen YJ, Wang SH, Chen SP, Raben T, Widen E, Hsu S, Hsieh FJ, Ho DR, Huang YH, Yang CH, Huang YS, Chen YF, Wu HM, Tsai PH, Huang KG, Chien CY, Ho YL, Wu MS, Kao JH, Liu YB, Juang JJ, Lin MH, Lin YH, Lee JY, Lu HJ, Lu CH, Feng AC, Liu JS, Chiang CP, Chu NF, Lin JC, Yeh YW, Meng E, Huang CY, Li CC, Wang TF, Su KY, Wang JK, Chen MH, Chen HF, Ma GC, Chang TY, Chiang FT, Chang HJ, Kao KJ, Hung CF, Tsai CY, Chen PY, Tsui K, Chen YT, Kwok PY, Sheu WH, Yang SF, Liou JM, Wang JY, Chiou JF, Wu JY, Fann CSJ. Population-specific polygenic risk scores for people of Han Chinese ancestry. Nature. 2025 Dec;648(8092):128-137. doi: 10.1038/s41586-025-09350-y. Epub 2025 Oct 15. PMID: 41094136; PMCID: PMC12675292. https://doi.org/10.1038/s41586-025-09350-y
    37. Chiu PH, Lai KC, Wang HL, Chang YW, Wu WC, Chen TH, Tsai YS, Song JH, Sun NY, Chau GY, Fang WL, Chen JP, Wang HM, Huang HC, Hsieh MC, Hua CH, Lien MY, Chang YF, Wang HC, Chien CY, Huang TL, Wang CC, Liu YC, Chen JP, Lu WC, Yiu CY, Lin CL, Lou PJ, Chu PY, Wang SC, Hung MC, Yang MH. Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy. Cell Rep Med. 2025 Nov 18;6(11):102448. doi: 10.1016/j.xcrm.2025.102448. https://doi.org/10.1016/j.xcrm.2025.102448
    38. Tsai MH, Yang CH, Tsai YT, Lin YT, Chao CY, Chuang HC, Huang TL, Lu H, Tsai WL, Chien CY*, Fang FM*. Controlling nutritional status score as a survival prognosticator in patients with head and neck cancer. J Formos Med Assoc. 2025 Apr 16:S0929-6646(25)00186-X. doi: 10.1016/j.jfma.2025.04.017. Epub ahead of print. PMID: 40246675. *co-corresponding https://doi.org/10.1016/j.jfma.2025.04.017
    39. Tsai MH, Yang CH, Lin YT, Chuang HC, Huang TL, Lu H, Tsai WL, Chien CY*, Fang FM*. Albumin-Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma. Kaohsiung J Med Sci. 2025 Sep 25:e70115. doi: 10.1002/kjm2.70115. Epub ahead of print. PMID: 40999594. *co-corresponding https://doi.org/10.1002/kjm2.70115

2024

    1. Chang CW, Hsu WF, Tseng KC, Chen CY, Cheng PN, Hung CH, Lo CC, Bair MJ, Chen CH, Lee PL, Lin CY, Kuo HT, Chen CT, Yang CC, Huang JF, Tai CM, Hu JT, Lin CL, Su WW, Tsai WL, Huang YH, Cheng CY, Lin CL, Wang CC, Yang SS, Mo LR, Chen GY, Chang CC, Wang SJ, Huang CS, Hsieh TY, Lin CW, Lee TH, Chong LW, Huang CW, Chang SN, Tsai MC, Hsu SJ, Kao JH, Liu CJ, Liu CH, Lin HC, Tsai PC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, Peng CY. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan. Dig Dis Sci. 2024 Sep;69(9):3501-3512. doi: 10.1007/s10620-024-08512-8. Epub 2024 Jul 4. PMID: 38965159. https://doi.org/10.1007/s10620-024-08512-8
    2. Chang WT, Huang PS, Su LW, Liao CT, Siong Toh H, Chen YC, Ho CH, Chen ZC, Hsu PC, Hong CS. Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. J Atheroscler Thromb. 2024 May 1;31(5):572-586. doi: 10.5551/jat.64326. Epub 2023 Dec 12. PMID: 38092392; PMCID: PMC11079481. https://doi.org/10.5551/jat.64326
    3. Chang WT, Lin CH, Lee WC, Kan WC, Lin YC, Hiremath P, Cheng S, Liao R, Chen ZC, Huang PS, Wu NC. Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome. Int J Cardiol. 2024 Jan 1;394:131367. doi: 10.1016/j.ijcard.2023.131367. Epub 2023 Sep 17. PMID: 37726056. https://doi.org/10.1016/j.ijcard.2023.131367
    4. Chang WT, Lin YW, Chen CY, Hong CS, Chen ZC, Lin YC, Shih JY. The Combination of Valsartan and Spironolactone Mitigated Mitral Regurgitation-Induced Cardiac Dysfunction in a Novel Rat Model. J Cardiovasc Pharmacol. 2024 Oct 1;84(4):410-417. doi: 10.1097/FJC.0000000000001614. PMID: 39115805. https://doi.org/10.1097/fjc.0000000000001614
    5. Chao TH, Lin TH, Cheng CI, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC, Wu CC, Lin CF, Chang WT, Pan WH, Chen PR, Ting KH, Su CH, Chu CS, Chien KL, Yen HW, Wang YC, Su TC, Liu PY, Chang HY, Chen PW, Juang JJ, Lu YW, Lin PL, Wang CP, Ko YS, Chiang CE, Hou CJ, Wang TD, Lin YH, Huang PH, Chen WJ. 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I. Acta Cardiol Sin. 2024 Sep;40(5):479-543. doi: 10.6515/ACS.202409_40(5).20240724A. PMID: 39308649; PMCID: PMC11413940. https://doi.org/10.6515/acs.202409_40(5).20240724a
    6. Chao TH, Lin TH, Cheng CI, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC, Wu CC, Lin CF, Chang WT, Pan WH, Chen PR, Ting KH, Su CH, Chu CS, Chien KL, Yen HW, Wang YC, Su TC, Liu PY, Chang HY, Chen PW, Juang JJ, Lu YW, Lin PL, Wang CP, Ko YS, Chiang CE, Hou CJ, Wang TD, Lin YH, Huang PH, Chen WJ. 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part II. Acta Cardiol Sin. 2024 Nov;40(6):669-715. doi: 10.6515/ACS.202411_40(6).20240724B. PMID: 39582845; PMCID: PMC11579689. https://doi.org/10.6515/acs.202411_40(6).20240724b
    7. Chen CY, Chang WT, Lin HW, Lin SH, Li YH. Statin Use Is Associated With Reduced Heart Failure and Risk of Death in Non-Hodgkin Lymphoma. JACC CardioOncol. 2024 Feb 20;6(1):133-135. doi: 10.1016/j.jaccao.2023.12.005. PMID: 38510293; PMCID: PMC10950425. https://doi.org/10.1016/j.jaccao.2023.12.005
    8. Chen YT, Chen TI, Yang TH, Yin SC, Lu SN, Liu XR, Gao YZ, Lin CJ, Huang CW, Huang JF, Yeh ML, Huang CF, Dai CY, Chuang WL, Yang HI, Yu ML, Lee MH. Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes. Am J Gastroenterol. 2024 Nov 1;119(11):2241-2250. doi: 10.14309/ajg.0000000000002778. Epub 2024 Mar 7. PMID: 38534155; PMCID: PMC11524626. https://doi.org/10.14309/ajg.0000000000002778
    9. Chen YT, Chen TI, Yin SC, Huang CW, Huang JF, Lu SN, Yeh ML, Huang CF, Dai CY, Chen YW, Chuang WL, Yu ML, Lee MH. Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease. J Gastroenterol Hepatol. 2024 Sep;39(9):1939-1949. doi: 10.1111/jgh.16592. Epub 2024 May 9. PMID: 38725327. https://doi.org/10.1111/jgh.16592
    10. Cheng PN, Chen WJ, Hou CJ, Lin CL, Chang ML, Wang CC, Chang WT, Wang CY, Lin CY, Hung CL, Peng CY, Yu ML, Chao TH, Huang JF, Huang YH, Chen CY, Chiang CE, Lin HC, Li YH, Lin TH, Kao JH, Wang TD, Liu PY, Wu YW, Liu CJ. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. Clin Mol Hepatol. 2024 Jan;30(1):16-36. doi: 10.3350/cmh.2023.0315. Epub 2023 Oct 4. PMID: 37793641; PMCID: PMC10776290. https://doi.org/10.3350/cmh.2023.0315
    11. Cheng PN, Feng IC, Chen JJ, Kuo HT, Lee PL, Yu ML, Chiu YC, Chiu HC, Chien SC, Chen PJ, Liu CJ. Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2024 Jan;59(2):230-238. doi: 10.1111/apt.17765. Epub 2023 Oct 16. PMID: 37845815. https://doi.org/10.1111/apt.17765
    12. Cheng PN, Yu ML. Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer. Clin Mol Hepatol. 2024 Apr;30(2):144-146. doi: 10.3350/cmh.2024.0115. Epub 2024 Feb 19. PMID: 38373418; PMCID: PMC11016484. https://doi.org/10.3350/cmh.2024.0115
    13. Cheng PN, Yu ML. Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide". Clin Mol Hepatol. 2024 Oct;30(4):1031-1032. doi: 10.3350/cmh.2024.0228. Epub 2024 Apr 11. PMID: 38600870; PMCID: PMC11540407. https://doi.org/10.3350/cmh.2024.0228
    14. Chong JH, Chang WT, Chan JJ, Tan TJY, Chan JWK, Wong M, Wong FY, Chuah CTH. The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction - A systematic review. Curr Probl Cardiol. 2024 Mar;49(3):102372. doi: 10.1016/j.cpcardiol.2024.102372. Epub 2024 Jan 27. PMID: 38281354. https://doi.org/10.1016/j.cpcardiol.2024.102372
    15. Hong RL, Yen CJ, Lien MY, Cheng R, Su YW, Lin HN, Poon SL, Chien CY. Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study. Oral Oncol. 2024 May;152:106760. doi: 10.1016/j.oraloncology.2024.106760. Epub 2024 Mar 23. PMID: 38520758. https://doi.org/10.1016/j.oraloncology.2024.106760
    16. Huang CC, Hsu CM, Chao MW, Hsu KC, Lin TE, Yen SC, Tu HJ, Pan SL. In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer. Protein Sci. 2024 Jun;33(6):e5004. doi: 10.1002/pro.5004. PMID: 38723164; PMCID: PMC11081522. https://doi.org/10.1002/pro.5004
    17. Huang CF, Awad MH, Gal-Tanamy M, Yu ML. Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on "Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication". Clin Mol Hepatol. 2024 Oct;30(4):1023-1025. doi: 10.3350/cmh.2024.0472. Epub 2024 Jul 1. PMID: 38946463; PMCID: PMC11540381. https://doi.org/10.3350/cmh.2024.0472
    18. Huang CF, Awad MH, Gal-Tanamy M, Yu ML. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication. Clin Mol Hepatol. 2024 Jul;30(3):326-344. doi: 10.3350/cmh.2024.0155. Epub 2024 Apr 26. PMID: 38665034; PMCID: PMC11261227. https://doi.org/10.3350/cmh.2024.0155
    19. Huang CF, Dai CY, Lin YH, Wang CW, Jang TY, Liang PC, Lin TC, Tsai PC, Wei YJ, Yeh ML, Hsieh MY, Huang CK, Huang JF, Chuang WL, Yu ML. Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan. Clin Mol Hepatol. 2024 Oct;30(4):883-894. doi: 10.3350/cmh.2024.0414. Epub 2024 Jul 29. PMID: 39069721; PMCID: PMC11540343. https://doi.org/10.3350/cmh.2024.0414
    20. Huang CF, Kroeniger K, Wang CW, Jang TY, Yeh ML, Liang PC, Wei YJ, Hsu PY, Huang CI, Hsieh MY, Lin YH, Huang JF, Dai CY, Chuang WL, Sharma A, Yu ML. Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis. J Clin Transl Hepatol. 2024 Nov 28;12(11):907-916. doi: 10.14218/JCTH.2024.00172. Epub 2024 Oct 14. PMID: 39544249; PMCID: PMC11557369. https://doi.org/10.14218/jcth.2024.00172
    21. Huang CF, Liang PC, Tsai PC, Wei YJ, Huang CI, Wang CW, Jang TY, Yeh ML, Hsu PY, Hsieh MY, Lin YH, Dai CY, Chuang WL, Huang JF, Yu ML. The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area. J Gastroenterol Hepatol. 2024 Jan;39(1):193-201. doi: 10.1111/jgh.16363. Epub 2023 Sep 20. PMID: 37731071. https://doi.org/10.1111/jgh.16363
    22. Huang CF, Liang PC, Wang CW, Jang TY, Hsu PY, Tsai PC, Wei YJ, Yeh ML, Hsieh MY, Lin YH, Huang CK, Dai CY, Huang JF, Chuang WL, Yu ML. Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis. Kaohsiung J Med Sci. 2024 Apr;40(4):374-383. doi: 10.1002/kjm2.12804. Epub 2024 Jan 17. PMID: 38234005; PMCID: PMC11895577. https://doi.org/10.1002/kjm2.12804
    23. Huang CF, Yeh ML, Dai CY, Huang JF, Chuang WL, Yu ML. Chronic Hepatitis C Related Steatotic Liver Disease Is More Than "Miscellaneous Steatotic Liver Disease". Clin Gastroenterol Hepatol. 2024 Oct;22(10):2137-2139.e2. doi: 10.1016/j.cgh.2024.04.023. Epub 2024 May 9. PMID: 38729391. https://doi.org/10.1016/j.cgh.2024.04.023
    24. Huang DQ, Hoang JK, Kamal R, Tsai PC, Toyoda H, Yeh ML, Yasuda S, Leong J, Maeda M, Huang CF, Won Jun D, Ishigami M, Tanaka Y, Uojima H, Ogawa E, Abe H, Hsu YC, Tseng CH, Alsudaney M, Yang JD, Yoshimaru Y, Suzuki T, Liu JK, Landis C, Dai CY, Huang JF, Chuang WL, Schwartz M, Dan YY, Esquivel C, Bonham A, Yu ML, Nguyen MH. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma. J Clin Oncol. 2024 Mar 1;42(7):790-799. doi: 10.1200/JCO.23.00757. Epub 2024 Jan 4. PMID: 38175991. https://doi.org/10.1200/jco.23.00757
    25. Huang JF, Chang TJ, Yeh ML, Shen FC, Tai CM, Chen JF, Huang YH, Hsu CY, Cheng PN, Lin CL, Hung CH, Chen CC, Lee MH, Lee CC, Lin CW, Liu SC, Yang HI, Chien RN, Kuo CS, Peng CY, Chang ML, Huang CF, Yang YS, Yang HC, Lin HC, Ou HY, Liu CJ, Tseng CH, Kao JH, Chuang WL, Huang CN, Chen PJ, Wang CY, Yu ML. Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus. Hepatol Commun. 2024 Oct 30;8(11):e0571. doi: 10.1097/HC9.0000000000000571. PMID: 39470335; PMCID: PMC11524742. https://doi.org/10.1097/hc9.0000000000000571
    26. Hung CL, Wu YW, Kuo L, Sung KT, Lin HH, Chang WT, Chang CH, Lai CH, Huang CY, Wang CL, Lin CC, Juang JJ, Chen PS, Wang CY, Chang HC, Chu CY, Wang WH, Tseng H, Kao YT, Wang TD, Yu WC, Chen WJ. 2024 Update of the TSOC Expert Consensus of Fabry Disease. Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A. PMID: 39308653; PMCID: PMC11413953. https://doi.org/10.6515/acs.202409_40(5).20240731a
    27. Jang TY, Ho CC, Liang PC, Wu CD, Wei YJ, Tsai PC, Hsu PY, Hsieh MY, Lin YH, Hsieh MH, Wang CW, Yang JF, Yeh ML, Huang CF, Chuang WL, Huang JF, Cheng YY, Dai CY, Chen PC, Yu ML. Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease. Kaohsiung J Med Sci. 2024 Mar;40(3):304-314. doi: 10.1002/kjm2.12781. Epub 2023 Nov 10. PMID: 37947277; PMCID: PMC11895598. https://doi.org/10.1002/kjm2.12781
    28. Jang TY, Huang CF, Chang TS, Yang CC, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Kuo HT, Yu ML. Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry. J Formos Med Assoc. 2025 Aug;124(8):731-737. doi: 10.1016/j.jfma.2024.08.013. Epub 2024 Aug 21. PMID: 39168745. https://doi.org/10.1016/j.jfma.2024.08.013
    29. Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino I E, Abe H, Takahashi H, Inoue K, Yeh ML, Dai CY, Huang JF, Huang CF, Chuang WL, Nguyen MH, Yu ML. Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study. J Gastroenterol Hepatol. 2024 Jun;39(6):1190-1197. doi: 10.1111/jgh.16537. Epub 2024 Mar 13. PMID: 38480009. https://doi.org/10.1111/jgh.16537
    30. Ji F, Tran S, Ogawa E, Huang CF, Suzuki T, Wong YJ, Toyoda H, Jun DW, Li L, Uojima H, Nozaki A, Chuma M, Tseng CH, Hsu YC, Ishigami M, Honda T, Atsukawa M, Haga H, Enomoto M, Trinh H, Preda CM, Vutien P, Landis C, Lee DH, Watanabe T, Takahashi H, Abe H, Asai A, Eguchi Y, Li J, Wang X, Li J, Liu J, Liang J, Lam CP, Huang R, Ye Q, Pan H, Zhang J, Cai D, Wang Q, Huang DQ, Wong G, Wong VW, Li J, Do S, Furusyo N, Nakamuta M, Nomura H, Kajiwara E, Yoon EL, Ahn SB, Azuma K, Dohmen K, An J, Song DS, Cho HC, Kawano A, Koyanagi T, Ooho A, Satoh T, Takahashi K, Yeh ML, Tsai PC, Yasuda S, Zhao Y, Liu Y, Okubo T, Itokawa N, Jun MJ, Ishikawa T, Takaguchi K, Senoh T, Zhang M, Zhao C, Alecu RI, Xuan Tay W, Devan P, Liu JK, Kozuka R, Vargas-Accarino E, Do AT, Maeda M, Chuang WL, Huang JF, Dai CY, Cheung R, Buti M, Niu J, Xie W, Ren H, Lim SG, Wu C, Yuen MF, Shang J, Zhu Q, Ueno Y, Tanaka Y, Hayashi J, Yu ML, Nguyen MH. Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study. J Clin Transl Hepatol. 2024 Jul 28;12(7):646-658. doi: 10.14218/JCTH.2024.00089. Epub 2024 Jun 17. PMID: 38993510; PMCID: PMC11233980. https://doi.org/10.14218/jcth.2024.00089
    31. Kelberman MA, Rodberg E, Arabzadeh E, Bair-Marshall CJ, Berridge CW, Berrocoso E, Breton-Provencher V, Chandler DJ, Che A, Davy O, Devilbiss DM, Downs AM, Drummond G, Dvorkin R, Fazlali Z, Froemke RC, Glennon E, Gold JI, Ito H, Jiang X, Johansen JP, Kaye AP, Kim JR, Kuo CC, Liu RJ, Liu Y, Llorca-Torralba M, McCall JG, McElligott ZA, McKinney AM, Miguelez C, Min MY, Nowlan AC, Omrani M, Poe GR, Pickering AE, Ranjbar-Slamloo Y, Razquin J, Rodenkirch C, Sales AC, Satyasambit R, Shea SD, Sur M, Tkaczynski JA, Torres-Sanchez S, Uematsu A, Vazquez CR, Vreven A, Wang Q, Waterhouse BD, Yang HW, Yang JH, Zhao L, Zouridis IS, Weinshenker D, Vazey E, Totah NK. Diversity of ancestral brainstem noradrenergic neurons across species and multiple biological factors. bioRxiv [Preprint]. 2024 Oct 16:2024.10.14.618224. doi: 10.1101/2024.10.14.618224. PMID: 39464004; PMCID: PMC11507722. https://doi.org/10.1101/2024.10.14.618224
    32. Kudaravalli S, Huang DQ, Yeh ML, Trinh L, Tsai PC, Hsu YC, Kam LY, Nguyen VH, Ogawa E, Lee DH, Ito T, Watanabe T, Enomoto M, Preda CM, Ko MKL, Wan-Hin Hui R, Atsukawa M, Suzuki T, Marciano S, Barreira A, Do S, Uojima H, Takahashi H, Quek SXZ, Toe Wai Khine HH, Ishigami M, Itokawa N, Go MS, Kozuka R, Marin RI, Sandra I, Li J, Zhang JQ, Wong C, Yoshimaru Y, Vo DKH, Tseng CH, Lee CJ, Inoue K, Maeda M, Hoang JK, Chau A, Chuang WL, Dai CY, Huang JF, Huang CF, Buti M, Tanaka Y, Gadano AC, Yuen MF, Cheung R, Lim SG, Trinh HN, Toyoda H, Yu ML, Nguyen MH. Sex and ethnic disparities in hepatitis B evaluation and treatment across the world. J Hepatol. 2024 Jul;81(1):33-41. doi: 10.1016/j.jhep.2024.02.033. Epub 2024 May 1. PMID: 38906621. https://doi.org/10.1016/j.jhep.2024.02.033
    33. Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, Yang HI, Chen HY, Chen CJ. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC. Clin Gastroenterol Hepatol. 2024 Jun;22(6):1275-1285.e2. doi: 10.1016/j.cgh.2024.01.045. Epub 2024 Feb 15. PMID: 38365094. https://doi.org/10.1016/j.cgh.2024.01.045
    34. Lee WC, Lin YW, Shih JY, Chen ZC, Wu NC, Chang WT. Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol. ESC Heart Fail. 2024 Feb;11(1):251-260. doi: 10.1002/ehf2.14577. Epub 2023 Nov 14. PMID: 37963437; PMCID: PMC10804175. https://doi.org/10.1002/ehf2.14577
    35. Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, Yang HI, Chen CJ. Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Aliment Pharmacol Ther. 2024 Apr;59(8):993-1002. doi: 10.1111/apt.17915. Epub 2024 Feb 27. PMID: 38410882. https://doi.org/10.1111/apt.17915
    36. Lin HY, Liang CJ, Yang MY, Chen PL, Wang TM, Chen YH, Shih YH, Liu W, Chiu CC, Chiang CK, Lin CS, Lin HC. Critical roles of tubular mitochondrial ATP synthase dysfunction in maleic acid-induced acute kidney injury. Apoptosis. 2024 Jun;29(5-6):620-634. doi: 10.1007/s10495-023-01897-3. Epub 2024 Jan 28. PMID: 38281282; PMCID: PMC11055741. https://doi.org/10.1007/s10495-023-01897-3
    37. Lin YC, Shih JY, Lin YW, Niu KC, Hong CS, Chen ZC, Pan SC, Chang TY, Kan WC, Chang WT. Hyperbaric Oxygen Therapy Improved Neovascularisation Following Limb Ischaemia-The Role of ROS Mitigation. J Cell Mol Med. 2024 Dec;28(24):e70310. doi: 10.1111/jcmm.70310. PMID: 39720917; PMCID: PMC11669187. https://doi.org/10.1111/jcmm.70310
    38. Liu CJ, Seto WK, Yu ML. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD. Hepatol Int. 2024 Oct;18(Suppl 2):897-908. doi: 10.1007/s12072-024-10699-x. Epub 2024 Aug 8. PMID: 39115632. https://doi.org/10.1007/s12072-024-10699-x
    39. Lonardo A, Bril F, Caldwell SH, Eslam M, Fan JG, Gish RG, Gronbaek H, Sanal MG, Stefan N, Suzuki A, Targher G, Tilg H, Yu ML, Zheng MH, George J. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature. J Hepatol. 2024 May;80(5):e192-e194. doi: 10.1016/j.jhep.2024.01.012. Epub 2024 Feb 9. PMID: 38336589. https://doi.org/10.1016/j.jhep.2024.01.012
    40. Lu MY, Chuang WL, Yu ML. The role of artificial intelligence in the management of liver diseases. Kaohsiung J Med Sci. 2024 Nov;40(11):962-971. doi: 10.1002/kjm2.12901. Epub 2024 Oct 23. PMID: 39440678; PMCID: PMC11895080. https://doi.org/10.1002/kjm2.12901
    41. Lu MY, Huang CF, Hung CH, Tai CM, Mo LR, Kuo HT, Tseng KC, Lo CC, Bair MJ, Wang SJ, Huang JF, Yeh ML, Chen CT, Tsai MC, Huang CW, Lee PL, Yang TH, Huang YH, Chong LW, Chen CL, Yang CC, Yang SS, Cheng PN, Hsieh TY, Hu JT, Wu WC, Cheng CY, Chen GY, Zhou GX, Tsai WL, Kao CN, Lin CL, Wang CC, Lin TY, Lin CL, Su WW, Lee TH, Chang TS, Liu CJ, Dai CY, Kao JH, Lin HC, Chuang WL, Peng CY, Tsai CW, Chen CY, Yu ML; TACR Study Group. Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program. Clin Mol Hepatol. 2024 Jan;30(1):64-79. doi: 10.3350/cmh.2023.0287. Epub 2023 Nov 21. PMID: 38195113; PMCID: PMC10776298. https://doi.org/10.3350/cmh.2023.0287
    42. Lu MY, Yu ML. Correspondence on Letter regarding "Toward hepatitis C virus elimination using artificial intelligence". Clin Mol Hepatol. 2024 Apr;30(2):274-275. doi: 10.3350/cmh.2024.0152. Epub 2024 Mar 5. PMID: 38439190; PMCID: PMC11016497. https://doi.org/10.3350/cmh.2024.0152
    43. Mukherji A, Jühling F, Simanjuntak Y, Crouchet E, Del Zompo F, Teraoka Y, Haller A, Baltzinger P, Paritala S, Rasha F, Fujiwara N, Gadenne C, Slovic N, Oudot MA, Durand SC, Ponsolles C, Schuster C, Zhuang X, Holmes J, Yeh ML, Abe-Chayama H, Heikenwälder M, Sangiovanni A, Iavarone M, Colombo M, Foung SKH, McKeating JA, Davidson I, Yu ML, Chung RT, Hoshida Y, Chayama K, Lupberger J, Baumert TF. An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection. Nat Commun. 2024 Aug 29;15(1):7486. doi: 10.1038/s41467-024-51698-8. PMID: 39209804; PMCID: PMC11362569. https://doi.org/10.1038/s41467-024-51698-8
    44. Pan Z, Khatry MA, Yu ML, Choudhury A, Sebastiani G, Alqahtani SA, Eslam M. MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight. Ther Adv Endocrinol Metab. 2024 May 27;15:20420188241252543. doi: 10.1177/20420188241252543. PMID: 38808010; PMCID: PMC11131400. https://doi.org/10.1177/20420188241252543
    45. Park JE, Nguyen VH, Tsai PC, Toyoda H, Leong J, Guy JE, Yeh ML, Huang CF, Yasuda S, Abe H, Hsu YC, Tseng CH, Liu J, Chen YL, Lin PY, Jun DW, Yoshimaru Y, Ogawa E, Ishigami M, Enomoto M, Tamori A, Uojima H, Wang XZ, Xu Q, Takahashi H, Eguchi Y, Inoue K, Huang DQ, Zhao WJ, Chuang WL, Dai CY, Huang JF, Barnett S, Maeda M, Cheung R, Landis C, Tanaka Y, Roberts LR, Schwartz ME, Kumada T, Yu ML, Nguyen MH. Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response. Aliment Pharmacol Ther. 2024 Mar;59(6):742-751. doi: 10.1111/apt.17863. Epub 2024 Jan 3. PMID: 38173278. https://doi.org/10.1111/apt.17863
    46. Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Nov 15;927:148660. doi: 10.1016/j.gene.2024.148660. Epub 2024 Jun 10. PMID: 38866261. https://doi.org/10.1016/j.gene.2024.148660
    47. Shih CI, Wu KT, Hsieh MH, Yang JF, Chen YY, Tsai WL, Chen WC, Liang PC, Wei YJ, Tsai PC, Hsu PY, Hsieh MY, Lin YH, Jang TY, Wang CW, Yeh ML, Huang CF, Huang JF, Dai CY, Ho CK, Chuang WL, Yu ML. Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study. Hepatol Int. 2024 Feb;18(1):138-154. doi: 10.1007/s12072-023-10576-z. Epub 2023 Sep 25. PMID: 37747618. https://doi.org/10.1007/s12072-023-10576-z
    48. Tai CM, Yu ML. Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide. Kaohsiung J Med Sci. 2024 Feb;40(2):112-118. doi: 10.1002/kjm2.12788. Epub 2023 Nov 27. PMID: 38010851; PMCID: PMC11895618. https://doi.org/10.1002/kjm2.12788
    49. Tsai PC, Huang CF, Yeh ML, Hsieh MH, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Chen CY, Huang JF, Dai CY, Chung WL, Bair MJ, Yu ML; T-COACH Study Group. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy. Clin Mol Hepatol. 2024 Jul;30(3):468-486. doi: 10.3350/cmh.2024.0038. Epub 2024 Apr 19. PMID: 38637957; PMCID: PMC11261235. https://doi.org/10.3350/cmh.2024.0038
    50. Tsai YT, Chen WC, Wen YW, Lin CY, Fan KH, Lin JC, Ng SH, Lee SR, Kang CJ, Lee LY, Chien CY, Hua CH, Wang CP, Chen TM, Terng SD, Tsai CY, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort study. BMC Cancer. 2024 Oct 25;24(1):1320. doi: 10.1186/s12885-024-13048-1. PMID: 39456017; PMCID: PMC11515095. https://doi.org/10.1186/s12885-024-13048-1
    51. Tu HJ, Chao MW, Lee CC, Peng CS, Wu YW, Lin TE, Chang YW, Yen SC, Hsu KC, Pan SL, HuangFu WC. Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation. J Enzyme Inhib Med Chem. 2024 Dec;39(1):2418470. doi: 10.1080/14756366.2024.2418470. Epub 2024 Nov 4. PMID: 39494990; PMCID: PMC11536634. https://doi.org/10.1080/14756366.2024.2418470
    52. Wang CW, Huang CF, Yeh ML, Chen SC, Hung CH, Kuo CH, Huang JF, Dai CY, Chuang WL, Lung-Yu M. Hepatitis C virus infection associated with coronary and thoracic aortic atherosclerosis. Am J Med Sci. 2024 Sep;368(3):203-213. doi: 10.1016/j.amjms.2024.02.004. Epub 2024 Feb 16. PMID: 38368945. https://doi.org/10.1016/j.amjms.2024.02.004
    53. Wang CW, Huang CF, Yeh ML, Liang PC, Jang TY, Wei YJ, Hsu PY, Hsieh MY, Lin YH, Huang JF, Dai CY, Chuang WL, Yu ML. Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality. Liver Int. 2024 Oct;44(10):2592-2604. doi: 10.1111/liv.16030. Epub 2024 Jul 10. PMID: 38984849. https://doi.org/10.1111/liv.16030
    54. Wang KC, Sun YS, Tsai HC, Liao HT, Lai CC, Chen WS, Lu LY, Chen MH. Increased risk of malignancy in HLA-B27-positive patients with ankylosing spondylitis requiring biologics for sustained inflammation: A long-term, single-center retrospective study. Mod Rheumatol. 2024 Aug 20;34(5):1027-1035. doi: 10.1093/mr/roae004. PMID: 38302085. https://doi.org/10.1093/mr/roae004
    55. Yang CC, Huang CF, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Kuo HT, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Yu ML. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan. Infect Dis Ther. 2024 Jun;13(6):1199-1213. doi: 10.1007/s40121-024-00968-5. Epub 2024 Apr 28. PMID: 38679663; PMCID: PMC11128429. https://doi.org/10.1007/s40121-024-00968-5
    56. Yen LJ, Chen YC, Wang KC, Shih MC, Li CL, Yu SJ, Lu LY. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes. Immunopharmacol Immunotoxicol. 2024 Feb;46(1):128-137. doi: 10.1080/08923973.2023.2281283. Epub 2024 Jan 21. PMID: 38059657. https://doi.org/10.1080/08923973.2023.2281283
    57. Younossi ZM, Alqahtani SA, Alswat K, Yilmaz Y, Keklikkiran C, Funuyet-Salas J, Romero-Gómez M, Fan JG, Zheng MH, El-Kassas M, Castera L, Liu CJ, Wai-Sun Wong V, Zelber-Sagi S, Allen AM, Lam B, Treeprasertsuk S, Hameed S, Takahashi H, Kawaguchi T, Schattenberg JM, Duseja A, Newsome PN, Francque S, Spearman CW, Castellanos Fernández MI, Burra P, Roberts SK, Chan WK, Arrese M, Silva M, Rinella M, Singal AK, Gordon S, Fuchs M, Alkhouri N, Cusi K, Loomba R, Ranagan J, Eskridge W, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Yu ML, Gerber L, Fornaresio L, Nader F, Henry L, Racila A, Golabi P, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. J Hepatol. 2024 Mar;80(3):419-430. doi: 10.1016/j.jhep.2023.11.004. Epub 2023 Nov 18. Erratum in: J Hepatol. 2025 May;82(5):945. doi: 10.1016/j.jhep.2025.01.018. PMID: 37984709. https://doi.org/10.1016/j.jhep.2023.11.004
    58. Younossi ZM, AlQahtani SA, Funuyet-Salas J, Romero-Gómez M, Yilmaz Y, Keklikkiran C, Alswat K, Yu ML, Liu CJ, Fan JG, Zheng MH, Burra P, Francque SM, Castera L, Schattenberg JM, Newsome PN, Allen AM, El-Kassas M, Treeprasertsuk S, Hameed S, Wai-Sun Wong V, Zelber-Sagi S, Takahashi H, Kawaguchi T, Castellanos Fernández MI, Duseja A, Arrese M, Rinella M, Singal AK, Gordon SC, Fuchs M, Eskridge W, Alkhouri N, Cusi K, Loomba R, Ranagan J, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Gerber L, Lam B, Fornaresio L, Nader F, Spearman CW, Roberts SK, Chan WK, Silva M, Racila A, Golabi P, Ananchuensook P, Henry L, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease. JHEP Rep. 2024 Mar 12;6(7):101066. doi: 10.1016/j.jhepr.2024.101066. Erratum in: JHEP Rep. 2025 Feb 17;7(3):101359. doi: 10.1016/j.jhepr.2025.101359. PMID: 39022387; PMCID: PMC11252535. https://doi.org/10.1016/j.jhepr.2024.101066
    59. Zeng XF, Varady KA, Wang XD, Targher G, Byrne CD, Tayyem R, Latella G, Bergheim I, Valenzuela R, George J, Newberry C, Zheng JS, George ES, Spearman CW, Kontogianni MD, Ristic-Medic D, Peres WAF, Depboylu GY, Yang W, Chen X, Rosqvist F, Mantzoros CS, Valenti L, Yki-Järvinen H, Mosca A, Sookoian S, Misra A, Yilmaz Y, Kim W, Fouad Y, Sebastiani G, Wong VW, Åberg F, Wong YJ, Zhang P, Bermúdez-Silva FJ, Ni Y, Lupsor-Platon M, Chan WK, Méndez-Sánchez N, de Knegt RJ, Alam S, Treeprasertsuk S, Wang L, Du M, Zhang T, Yu ML, Zhang H, Qi X, Liu X, Pinyopornpanish K, Fan YC, Niu K, Jimenez-Chillaron JC, Zheng MH. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus. Metabolism. 2024 Dec;161:156028. doi: 10.1016/j.metabol.2024.156028. Epub 2024 Sep 11. PMID: 39270816. https://doi.org/10.1016/j.metabol.2024.156028
    60. Zhang H, Targher G, Byrne CD, Kim SU, Wong VW, Valenti L, Glickman M, Ponce J, Mantzoros CS, Crespo J, Gronbaek H, Yang W, Eslam M, Wong RJ, Machado MV, Yu ML, Ghanem OM, Okanoue T, Liu JF, Lee YH, Xu XY, Pan Q, Sui M, Lonardo A, Yilmaz Y, Zhu LY, Moreno C, Miele L, Lupsor-Platon M, Zhao L, LaMasters TL, Gish RG, Zhang H, Nedelcu M, Chan WK, Xia MF, Bril F, Shi JP, Datz C, Romeo S, Sun J, Liu D, Sookoian S, Mao YM, Méndez-Sánchez N, Wang XY, Pyrsopoulos NT, Fan JG, Fouad Y, Sun DQ, Giannini C, Chai J, Xia ZF, Jun DW, Li GJ, Treeprasertsuk S, Li YX, Cheung TT, Zhang F, Goh GB, Furuhashi M, Seto WK, Huang H, Di Sessa A, Li QH, Cholongitas E, Zhang L, Silveira TR, Sebastiani G, Adams LA, Chen W, Qi X, Rankovic I, De Ledinghen V, Lv WJ, Hamaguchi M, Kassir R, Müller-Wieland D, Romero-Gomez M, Xu Y, Xu YC, Chen SY, Kermansaravi M, Kuchay MS, Lefere S, Parmar C, Lip GYH, Liu CJ, Åberg F, Lau G, George J, Sarin SK, Zhou JY, Zheng MH; MAFLD ICD-11 coding collaborators. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2024 Aug;18(4):1178-1201. doi: 10.1007/s12072-024-10702-5. Epub 2024 Jun 15. PMID: 38878111. https://doi.org/10.1007/s12072-024-10702-5

2023

    1. Chang WT, Lee WC, Lin YW, Shih JY, Hong CS, Chen ZC, Chu CY, Hsu CH. Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension. J Am Heart Assoc. 2023 Dec 5;12(23):e031435. doi: 10.1161/JAHA.123.031435. Epub 2023 Nov 28. PMID: 38014665; PMCID: PMC10727351. https://doi.org/10.1161/jaha.123.031435
    2. Chang WT, Liu CC, Huang YT, Wu JY, Tsai WW, Hung KC, Chen IW, Feng PH. Diagnostic efficacy of the triglyceride-glucose index in the prediction of contrast-induced nephropathy following percutaneous coronary intervention. Front Endocrinol (Lausanne). 2023 Nov 22;14:1282675. doi: 10.3389/fendo.2023.1282675. PMID: 38075076; PMCID: PMC10703478. https://doi.org/10.3389/fendo.2023.1282675
    3. Chang WT, Sun CK, Wu JY, Yu CH, Chang YJ, Lin MC, Lan KM, Chen IW, Hung KC. Association of prognostic nutritional index with long-term mortality in patients receiving percutaneous coronary intervention for acute coronary syndrome: a meta-analysis. Sci Rep. 2023 Aug 11;13(1):13102. doi: 10.1038/s41598-023-40312-4. PMID: 37567925; PMCID: PMC10421894. https://doi.org/10.1038/s41598-023-40312-4
    4. Chang WT, Wu CC, Liao IC, Lin YW, Chen YC, Ho CH, Lee WC, Lin YC, Chen ZC, Shih JY, Wu NC, Kan WC. Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-A translational study. Free Radic Biol Med. 2023 Nov 1;208:103-111. doi: 10.1016/j.freeradbiomed.2023.08.013. Epub 2023 Aug 5. Erratum in: Free Radic Biol Med. 2025 Jun;233:422-423. doi: 10.1016/j.freeradbiomed.2025.04.002. PMID: 37549754. https://doi.org/10.1016/j.freeradbiomed.2023.08.013
    5. Chen CY, Chen TT, Feng YA, Yu M, Lin SC, Longchamps RJ, Wang SH, Hsu YH, Yang HI, Kuo PH, Daly MJ, Chen WJ, Huang H, Ge T, Lin YF. Analysis across Taiwan Biobank, Biobank Japan, and UK Biobank identifies hundreds of novel loci for 36 quantitative traits. Cell Genom. 2023 Nov 16;3(12):100436. doi: 10.1016/j.xgen.2023.100436. Erratum in: Cell Genom. 2024 Sep 11;4(9):100640. doi: 10.1016/j.xgen.2024.100640. PMID: 38116116; PMCID: PMC10726425. https://doi.org/10.1016/j.xgen.2023.100436
    6. Huang CF, Jang TY, Wu PH, Kuo MC, Yeh ML, Wang CW, Liang PC, Wei YJ, Hsu PY, Huang CI, Hsieh MY, Lin YH, Hsiao HH, Hsu CM, Huang CT, Lee CY, Chen YH, Chen TC, Lin KD, Wang SH, Wang SF, Huang JF, Dai CY, Chuang WL, Yu ML. Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort. Virol J. 2023 Jun 2;20(1):112. doi: 10.1186/s12985-023-02056-5. PMID: 37268999; PMCID: PMC10237078. https://doi.org/10.1186/s12985-023-02056-5
    7. Huang CT, Lee CP, Chen TY, Liu YC, Cho SF, Du JS, Yu ML, Huang CF, Wang SF, Hsiao HH. Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies. J Clin Med. 2023 Aug 30;12(17):5647. doi: 10.3390/jcm12175647. PMID: 37685720; PMCID: PMC10488979. https://doi.org/10.3390/jcm12175647
    8. Huang JF, Tsai PC, Yeh ML, Huang CF, Huang CI, Lee MH, Hsu PY, Wang CW, Wei YJ, Liang PC, Lin YH, Hsieh MH, Yang JF, Hsieh MY, Jang TY, Bair MJ, Lin ZY, Dai CY, Yu ML, Chuang WL. Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease. J Clin Transl Hepatol. 2023 Oct 28;11(5):1061-1068. doi: 10.14218/JCTH.2022.00103S. Epub 2023 May 24. PMID: 37577215; PMCID: PMC10412709. https://doi.org/10.14218/jcth.2022.00103s
    9. Lee S, Chao MW, Wu YW, Hsu CM, Lin TE, Hsu KC, Pan SL, Lee HY. Synthesis and evaluation of potent (iso)ellipticine-based inhibitors of MYLK4 accessed via expeditious synthesis from isoquinolin-5-ol. RSC Adv. 2023 Oct 30;13(45):31595-31601. doi: 10.1039/d3ra06600b. PMID: 37908644; PMCID: PMC10613853. https://doi.org/10.1039/d3ra06600b
    10. Lin ZY, Yeh ML, Liang PC, Hsu PY, Huang CF, Huang JF, Dai CY, Yu ML, Chuang WL. Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy. Cancers (Basel). 2023 Oct 22;15(20):5097. doi: 10.3390/cancers15205097. PMID: 37894463; PMCID: PMC10605131. https://doi.org/10.3390/cancers15205097
    11. Lu CY, Kao CL, Hung KC, Wu JY, Hsu HC, Yu CH, Chang WT, Feng PH, Chen IW. Diagnostic efficacy of serum presepsin for postoperative infectious complications: a meta-analysis. Front Immunol. 2023 Dec 12;14:1320683. doi: 10.3389/fimmu.2023.1320683. PMID: 38149257; PMCID: PMC10750271. https://doi.org/10.3389/fimmu.2023.1320683
    12. Peng BR, Zheng LG, Chen LY, El-Shazly M, Hwang TL, Su JH, Lee MH, Lai KH, Sung PJ. Nor-24-homoscalaranes, Neutrophilic Inflammatory Mediators from the Marine Sponge Lendenfeldia sp. Pharmaceuticals (Basel). 2023 Sep 6;16(9):1258. doi: 10.3390/ph16091258. PMID: 37765066; PMCID: PMC10537518. https://doi.org/10.3390/ph16091258
    13. Perez S, Lavi-Itzkovitz A, Gidoni M, Domovitz T, Dabour R, Khurana I, Davidovich A, Tobar A, Livoff A, Solomonov E, Maman Y, El-Osta A, Tsai Y, Yu ML, Stemmer SM, Haviv I, Yaari G, Gal-Tanamy M. High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures. Cell Mol Gastroenterol Hepatol. 2023;16(1):63-81. doi: 10.1016/j.jcmgh.2023.03.004. Epub 2023 Mar 24. PMID: 36965814; PMCID: PMC10212990. https://doi.org/10.1016/j.jcmgh.2023.03.004
    14. Shih MC, Li CL, Liao EC, Yen CY, Yen LJ, Wang KC, Lu LY, Chou TY, Chen YC, Yu SJ. Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment. Int J Mol Sci. 2023 Aug 31;24(17):13528. doi: 10.3390/ijms241713528. PMID: 37686332; PMCID: PMC10487783. https://doi.org/10.3390/ijms241713528
    15. Tsai YC, Yu ML, Ko CY, Hsin YH, Tsai QZ, Huang CW. Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis. BMJ Open. 2023 Jun 7;13(6):e070490. doi: 10.1136/bmjopen-2022-070490. PMID: 37286314; PMCID: PMC10254962. https://doi.org/10.1136/bmjopen-2022-070490
    16. Yu ML, Ward JW. Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs. J Infect Dis. 2023 Sep 13;228(Suppl 3):S145-S147. doi: 10.1093/infdis/jiad342. PMID: 37703338. https://doi.org/10.1093/infdis/jiad342
瀏覽數: